Skip to content
healthcare.dev
Get a free key

Anastrozole

NDC 87063-224, Anastrozole Tablets, tablet, from ASCLEMED USA INC..

Product NDC
87063-224
Status
Listed
Labeler
ASCLEMED USA INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206037
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87063-224 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANASTROZOLE1 mg/1

Pharmacologic classes

Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]

Package NDCNDC-11Package
87063-224-0587063022405500 TABLET in 1 BOTTLE (87063-224-05)
87063-224-308706302243030 TABLET in 1 BOTTLE (87063-224-30)
87063-224-608706302246060 TABLET in 1 BOTTLE (87063-224-60)
87063-224-908706302249090 TABLET in 1 BOTTLE (87063-224-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/39df1668-8344-4c42-9bd7-7907bd571f6e

Use it

Look up 87063-224 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87063-224 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87063-224. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.